Results 281 to 290 of about 9,492,165 (393)
STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy
STING agonists show promise in preclinical studies in boosting an anti‐tumor response using the immune system. However, different limitations remain, and future research is needed to better understand how STING activation impacts the tumor microenvironment, identify effective combination strategies, and determine the best tumor types for STING agonist ...
Laura Gehrcken+3 more
wiley +1 more source
Psoriasis: a mixed autoimmune and autoinflammatory disease.
Yun Liang+3 more
semanticscholar +1 more source
This study uncovers that CD38high monocytes discriminate sepsis and sterile inflammation and are associated with 28‐day mortality in bacterial sepsis. Targeting CD38 therapy reduces inflammatory response in monocytes and in sepsis mice model. Mechanistically, CD38‐HIF‐1α/glycolysis/MGO loop exacerbates sepsis‐induced immune dysregulation.
Ning Hua+19 more
wiley +1 more source
Application of novel CAR technologies to improve treatment of autoimmune disease. [PDF]
Cheever A+3 more
europepmc +1 more source
This study develops lipid nanoparticles (LNPs) combining cationic and ionizable lipids for efficient cytosolic protein delivery. Optimized LNPs deliver functional proteins, including antibodies, enzymes, and Cas9, with high serum stability and albumin‐mediated endocytosis.
Lanfang Ren+6 more
wiley +1 more source
Author Correction: B cell depletion therapies in autoimmune disease: advances and mechanistic insights. [PDF]
Lee DSW, Rojas OL, Gommerman JL.
europepmc +1 more source
Targeted regulation of pyroptosis to modulate the immune landscape is a novel design strategy for cancer immunotherapy and anti‐inflammatory treatment. Pyroptosis, as a double‐edged sword, underscores the importance of optimizing the design strategy of functional materials and appropriately activating pyroptosis for the effective treatment of diseases.
Luyao Tian+5 more
wiley +1 more source